ArticleScientific reports2023

CSE1L is a negative regulator of the RB-DREAM pathway in p53 wild-type NSCLC and can be targeted using an HDAC1/2 inhibitor.

Lei Duan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.